Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: dyslipidemia
Total 0 results
Nothing found
Sponsors and Collaborators
Donders Institute for Brain, Cognition and Behavior
Fondren Orthopedic Group L.L.P.
Alberta Children's Hospital, Calgary, Canada
Celtaxsys Aus Pty Limited
Victor Montori
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
San MediTech(Huzhou)Co.,Ltd.
Elim Pediatric Pharmaceuticals Inc.
Societa Italiana di Endoscopia Digestiva
Caritas Freetown
ProteoSys AG
Norsk Proteinintolerance, Norway
University Medical Center Goettingen
Cardresearch
CRMBM-CEMEREM
The Fifth Affiliated Hospital of Zunyi Medical College
Diego Hernan Giunta, MD
AMTC & Associates
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Rui-hua Xu, MD, PhD
View Full List
Medical Conditions
Disturbance of Activity and Attention
Non-dystrophic Myotonias
Tularaemia
Stereotactic Radioablation for Ventricular Tachycardia
Tube Disorders Eustachian
Normal Diameter of Optic Nerve
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Atrial Fibrillation, Postoperative
Malignant Ascites Due to Epithelial Carcinoma
Fever, Sweats, and Hot Flashes
Fibromyalgia Syndrome, Primary
Gynecologic Cancer
Orbital Tumor
Prostate Cancer Recurrent
Non-compressible Torso Hemorrhage
Auditory Hallucination, Verbal
Plasmodium Falciparum Malaria (Drug Resistant)
Spermatogenesis Arrest
Postcomatose Unawareness State
Lymphedema of Arm
View Full List
Drug Interventions
Topotecan
PF-00868554
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Indoximod
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Mupirocin Calcium
Polyethylene glycol 3350
SERETIDE Diskus
Ruxolitinib
Epimedium Prenylflavonoids Extract
Enzalutamide, Abiraterone
Cytarabine ARA-C
Insulin
Atezolizumab
Oxycodone, fentanyl
Cetrorelix 78 mg + 78 mg
Methotrexate
Lamivudine
Flibanserin 100 mg dose every evening
Bortezomib/dexamethasone
View Full List
CROs by country
Contract Research Organizations in Brazil
Contract Research Organizations in Cameroon
Contract Research Organizations in Congo
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Ecuador
Contract Research Organizations in Gambia
Contract Research Organizations in Georgia
Contract Research Organizations in Madagascar
Contract Research Organizations in Malaysia
Contract Research Organizations in Myanmar
Contract Research Organizations in Portugal
Contract Research Organizations in Slovakia
Contract Research Organizations in Sri Lanka
CRO list by country
CROs in Finland
SGS
Crown CRO
ProPharma Group
Dokumeds
Medfiles
LINK Medical
IRW Consulting
Parexel
Charles River Laboratories
IQVIA
All CROs in Finland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe